China Pharma Holdings, Inc.
CPHI
$1.50
-$0.0634-4.06%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.63% | -43.76% | -142.51% | -100.82% | 2.53% |
| Total Depreciation and Amortization | -35.60% | 2.02% | 6.40% | 7.93% | 8.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4,200.00% | 1,541.94% | 1,383.75% | 79.00% | -99.56% |
| Change in Net Operating Assets | 99.90% | -70.59% | 159.49% | 78.28% | -54.98% |
| Cash from Operations | 1,169.51% | -104.67% | 66.40% | 60.14% | -103.81% |
| Capital Expenditure | -333.33% | 231.43% | 49.82% | -- | -116.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5,964.44% | 113.63% | -724.44% | -- | -116.48% |
| Total Debt Issued | -99.36% | 133.66% | 55,411.11% | -98.67% | 86.13% |
| Total Debt Repaid | 100.00% | 100.00% | -- | -- | 16.88% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -77.63% | 101.43% | 666.67% | -98.67% | 104.52% |
| Foreign Exchange rate Adjustments | -227.38% | 126.67% | 89.63% | -121.61% | 1,192.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -270.00% | -104.40% | 62.45% | 32.21% | 195.91% |